☆ 4.7 Editorial Material

Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

ANNALS OF ONCOLOGY (2019)

Get Full Text
Add to Collection

Journal

ANNALS OF ONCOLOGY
Volume 30, Issue 5, Pages 663-665

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdz119

Keywords

-

Categories

Oncology

Funding

  1. Barcode for Life Foundation
  2. Dutch Cancer Society [10014]
  3. Bristol-Myers Squibb
  4. Eisai
  5. Novartis
  6. Merck Sharp Dohme
  7. Pfizer
  8. Roche
  9. Amgen
  10. AstraZeneca
  11. Bayer
  12. Boehringer Ingelheim

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.